VASCULAR THERAPEUTICS
Vascular Therapeutics is a developer of therapeutic agents to prevent and treat life-threatening thrombotic diseases. It focuses on developing glycotherapeutic agents to treat cardiovascular diseases caused by blood clots (thrombi) such as acute myocardial infarction (or heart attack), angina, stroke, pulmonary embolism, and deep vein thrombosis. The company was founded in 1994 and is headquartered in Mountain View, California.
VASCULAR THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1994-01-01
Address:
Mountain View, California, United States
Country:
United States
Status:
Active
Similar Organizations
Aerami Therapeutics
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.
Theraclone Sciences
Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation.
Transposon Therapeutics
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
VESSL Therapeutics
VESSL Therapeutics develops therapeutic modalities for cardiovascular medicine based on gene and cell therapies.
More informations about "Vascular Therapeutics"
About - Vascular Therapies
Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus …See details»
Vascular Therapies | Improving Vascular Access
It is used in kidney transplant patients and with vascular devices to reduce blood vessel narrowing. During surgery to create the fistula, Sirogen™ is applied at the area of the fistula …See details»
Vascular Therapeutics - PitchBook
Vascular Therapeutics General Information Description. Developer of therapeutic agents to prevent and treat life-threatening thrombotic diseases. The company focuses on developing …See details»
Vascular Therapies - Crunchbase Company Profile
Organization. Vascular Therapies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
News - Vascular Therapies
Vascular Therapies is developing a proprietary sirolimus formulation (Sirogen) for intraoperative local, perivascular drug delivery. In a post-hoc subgroup analysis from ACCESS, the original …See details»
CRF
The Cardiovascular Research Foundation is a nonprofit dedicated to helping doctors improve survival and quality of life for people suffering from heart disease. CRF The Cardiovascular Research Foundation (CRF) is an independent, …See details»
Vasocure - Crunchbase Company Profile & Funding
Vasocure is a vascular therapeutics enterprise in clinical development that uses a peptide to treat neointimal disease and atherosclerosis. They're a pharmaceutical firm with nephrology, cardiology, and oncology candidates. Their precision …See details»
Vascular Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Vascular Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
Vascular Biology 2021 - North American Vascular …
Vascular Biology 2021 is the annual meeting of the North American Vascular Biology Organization. Online October 25-29, 2021. Major themes are Developmental Vascular Biology, Genetics, Vascular Matrix Biology and …See details»
Centenara Labs AG
Our innovative organization is focused on transforming the most promising discoveries in aging research into therapies that extend people’s good health years and improve overall lifespan. ...See details»
Cardiovascular Therapeutics - Wiley Online Library
Cardiovascular Therapeutics is an open access journal publishing original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of novel …See details»
Therapeutic Vascularization for Tissue Regeneration
Jul 9, 2020 Scientist, Division of Experimental Therapeutics Toronto General Hospital Research Institute University Health Network. Institute of Biomaterials and Biomedical Engineering ...See details»
Vascular Therapies
CRESSKILL, N.J. (Mar. 29, 2022) – Vascular Therapies, Inc. a clinical-stage biopharma company focused on improving vascular access outcomes in patients with kidney disease, today …See details»
Vascular Interventions/Innovations and Therapeutic Advances …
This project will inhibit a pathway involved in pulmonary vascular remodeling and assess the potential of these inhibitors as possible new medicines for pulmonary arterial hypertension …See details»
Amgen CEO Bob Bradway's 2024 Letter to Shareholders
Apr 2, 2025 and development (IPR&D) charge associated with our Five Prime Therapeutics acquisition in 2021. Non-GAAP operating margin is calculated as a percentage of product …See details»
VASCULAR INSTITUTE OF VIRGINIA LLC NPI 1942509989 Internal …
Mar 16, 2011 NPI Profile for Vascular Institute Of Virginia Llc internist in 14085 Crown Ct Woodbridge, Va 22193. Phone: (703) 763-5224 . Taxonomy 207RN0300X Accepts:See details»
Vasomune - Crunchbase Company Profile & Funding
Vasomune Therapeutics is a private biotechnology company developing therapies to target diseases associated with blood vessel (vascular) dysfunction and destabilization. The inner …See details»
Relay Therapeutics Extends Cash Runway into 2029 Amid Clinical …
19 hours ago Relay Therapeutics extends cash runway to 2029, initiates Phase 3 ReDiscover-2 trial and Phase 1 vascular ... of strategic choices made to streamline the research organization …See details»
Relay Therapeutics Reports First Quarter 2025 Financial Results …
19 hours ago Relay Therapeutics, Inc. Cash runway extended into 2029. Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025. Initiated Phase 1 RLY-2608 vascular malformations …See details»
AAR WOODBRIDGE IMAGING CENTER NPI 1356507412 Radiology
Jul 29, 2008 Organization Location Address 4001 PRINCE WILLIAM PKWY SUITE 302 WOODBRIDGE, VA 22192 Location Phone ... Radiology Vascular & Interventional Radiology : …See details»